Literature DB >> 19893207

Virological, immune and host genetics markers in the control of HIV infection.

Beatriz Mothe1, Javier Ibarrondo, Anuska Llano, Christian Brander.   

Abstract

HIV infection, if left untreated, leads in most cases to the development of wide immune deterioration, opportunistic infections and eventually AIDS and death. The identification of individuals who despite persisting infection show no or few signs of HIV disease progression has spurred hopes that an effective HIV vaccine could be attainable. The design of such a vaccine will greatly depend on the precise definition of disease markers, host genetic and immune characteristics that mediate relative in vivo control of this virus. Accordingly, a number of viral factors and host genetic characteristics have been shown to play a crucial role in the control of HIV disease by delaying progression to AIDS or even preventing infection. There is also an improved understanding of humoral and cellular immune responses in terms of specificity, functional repertoire, longevity and tissue distribution and their ability to contain HIV replication. However, the definition of good immune correlates unequivocally and causally associated with protection or disease progression remains elusive. Here we review work on viral factors, host genetic markers and immunological determinants that have been identified in individuals with superior control of HIV infection or in subjects who remain uninfected despite frequent exposure to the viral pathogen.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19893207      PMCID: PMC3835054          DOI: 10.3233/DMA-2009-0655

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  24 in total

1.  Impact of HLA-B*81-associated mutations in HIV-1 Gag on viral replication capacity.

Authors:  Jaclyn K Wright; Vanessa L Naidoo; Zabrina L Brumme; Jessica L Prince; Daniel T Claiborne; Philip J R Goulder; Mark A Brockman; Eric Hunter; Thumbi Ndung'u
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

2.  Lack of association between HLA class II alleles and in vitro replication capacities of recombinant viruses encoding HIV-1 subtype C Gag-protease from chronically infected individuals.

Authors:  Jaclyn K Wright; Zabrina L Brumme; Boris Julg; Mary van der Stok; Zenele Mncube; Xiaojiang Gao; Jonathan M Carlson; Philip J R Goulder; Bruce D Walker; Mark A Brockman; Thumbi Ndung'u
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

3.  Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C.

Authors:  Jaclyn K Wright; Vladimir Novitsky; Mark A Brockman; Zabrina L Brumme; Chanson J Brumme; Jonathan M Carlson; David Heckerman; Bingxia Wang; Elena Losina; Mopo Leshwedi; Mary van der Stok; Lungile Maphumulo; Nompumelelo Mkhwanazi; Fundisiwe Chonco; Philip J R Goulder; Max Essex; Bruce D Walker; Thumbi Ndung'u
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

4.  High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control.

Authors:  Christoph T Berger; Nicole Frahm; David A Price; Beatriz Mothe; Musie Ghebremichael; Kari L Hartman; Leah M Henry; Jason M Brenchley; Laura E Ruff; Vanessa Venturi; Florencia Pereyra; John Sidney; Alessandro Sette; Daniel C Douek; Bruce D Walker; Daniel E Kaufmann; Christian Brander
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

Review 5.  Can we just kick-and-kill HIV: possible challenges posed by the epigenetically controlled interplay between HIV and host immunity.

Authors:  Marta Ruiz-Riol; Christian Brander
Journal:  Immunotherapy       Date:  2019-06-20       Impact factor: 4.196

6.  Plasma proteomic analysis of simian immunodeficiency virus infection of rhesus macaques.

Authors:  Jayme L Wiederin; Robert M Donahoe; James R Anderson; Fang Yu; Howard S Fox; Howard E Gendelman; Pawel S Ciborowski
Journal:  J Proteome Res       Date:  2010-09-03       Impact factor: 4.466

7.  Recombinant rubella vectors elicit SIV Gag-specific T cell responses with cytotoxic potential in rhesus macaques.

Authors:  Margherita Rosati; Candido Alicea; Viraj Kulkarni; Konstantin Virnik; Max Hockenbury; Niranjan Y Sardesai; George N Pavlakis; Antonio Valentin; Ira Berkower; Barbara K Felber
Journal:  Vaccine       Date:  2015-03-21       Impact factor: 3.641

8.  Alternative effector-function profiling identifies broad HIV-specific T-cell responses in highly HIV-exposed individuals who remain uninfected.

Authors:  Marta Ruiz-Riol; Anuska Llano; Javier Ibarrondo; Jennifer Zamarreño; Karina Yusim; Vanessa Bach; Beatriz Mothe; Susana Perez-Alvarez; Marco A Fernandez; Gerard Requena; Michael Meulbroek; Ferran Pujol; Agathe Leon; Patricia Cobarsi; Bette T Korber; Bonaventura Clotet; Carmela Ganoza; Jorge Sanchez; Josep Coll; Christian Brander
Journal:  J Infect Dis       Date:  2014-09-23       Impact factor: 5.226

9.  Comparative analysis of SIV-specific cellular immune responses induced by different vaccine platforms in rhesus macaques.

Authors:  Antonio Valentin; Katherine McKinnon; Jinyao Li; Margherita Rosati; Viraj Kulkarni; Guy R Pilkington; Jenifer Bear; Candido Alicea; Diego A Vargas-Inchaustegui; L Jean Patterson; Poonam Pegu; Namal P M Liyanage; Shari N Gordon; Monica Vaccari; Yichuan Wang; Alison E Hogg; Blake Frey; Yongjun Sui; Steven G Reed; Niranjan Y Sardesai; Jay A Berzofsky; Genoveffa Franchini; Marjorie Robert-Guroff; Barbara K Felber; George N Pavlakis
Journal:  Clin Immunol       Date:  2014-09-16       Impact factor: 3.969

10.  TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell Responses.

Authors:  Bruna Oriol-Tordera; Alex Olvera; Clara Duran-Castells; Anuska Llano; Beatriz Mothe; Marta Massanella; Judith Dalmau; Carmela Ganoza; Jorge Sanchez; Maria Luz Calle; Bonaventura Clotet; Javier Martinez-Picado; Eugènia Negredo; Julià Blanco; Dennis Hartigan-O'Connor; Christian Brander; Marta Ruiz-Riol
Journal:  J Immunol       Date:  2020-11-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.